Sign In
Buy TECH
$56.26
+0.650 (+1.17%)
At Close: Jun 23, 2026
Bio-Techne Corporation (TECH) Presents at Jefferies London Healthcare Conference 2025 Transcript
09:43am, Thursday, 20'th Nov 2025
Bio-Techne Corporation ( TECH ) Jefferies London Healthcare Conference 2025 November 20, 2025 7:30 AM EST Company Participants James Hippel - Executive VP of Finance & CFO Conference Call Participants
Bio-Techne Corporation (TECH) Presents at Stephens Annual Investment Conference 2025 Transcript
04:38pm, Tuesday, 18'th Nov 2025
Bio-Techne Corporation ( TECH ) Stephens Annual Investment Conference 2025 November 18, 2025 9:00 AM EST Company Participants James Hippel - Executive VP of Finance & CFO William Geist - President of
Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio
06:30am, Tuesday, 18'th Nov 2025
Partnership strengthens Bio-Techne's leadership in AI-enabled protein innovation NovoBody™ Duo molecules offer multi-specific binding capabilities for advanced research and diagnostics Collaboration
Brokerages Set Bio-Techne Corp (NASDAQ:TECH) Target Price at $71.17
02:20am, Tuesday, 18'th Nov 2025
Shares of Bio-Techne Corp (NASDAQ: TECH - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the sixteen analysts that are covering the firm, Marketbeat Ratings repo
PRESS RELEASE: CMB.TECH announces Q3 2025 results on 26/11/2025
02:15am, Friday, 14'th Nov 2025
Antwerp, Nov. 14, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMBT”, “CMB.TECH” or “the Company”) will release its third quarter 2025 earnings prior to market open
Bio-Techne Corporation (TECH) Presents at Stifel 2025 Healthcare Conference Transcript
11:41am, Tuesday, 11'th Nov 2025
Bio-Techne Corporation ( TECH ) Stifel 2025 Healthcare Conference November 11, 2025 9:20 AM EST Company Participants Kim Kelderman - CEO, President & Director James Hippel - Executive VP of Finance &
Bio-Techne Corporation (TECH) Presents at UBS Global Healthcare Conference 2025 Transcript
01:01pm, Monday, 10'th Nov 2025
Bio-Techne Corporation ( TECH ) UBS Global Healthcare Conference 2025 November 10, 2025 10:15 AM EST Company Participants Kim Kelderman - CEO, President & Director James Hippel - Executive VP of Finan
Bio-Techne to Present at Upcoming Investor Conferences
07:00am, Thursday, 06'th Nov 2025
MINNEAPOLIS , Nov. 6, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences: UBS Global Healthcare Conference 2025 Novem
Bio-Techne Corporation (TECH) Q1 2026 Earnings Call Transcript
01:11pm, Wednesday, 05'th Nov 2025
Bio-Techne Corporation ( TECH ) Q1 2026 Earnings Call November 5, 2025 9:00 AM EST Company Participants David Clair - VP of Investor Relations & Corporate Development Kim Kelderman - CEO, President &
TECH Stock Falls on Q1 Earnings Meet, Revenues Miss, Margins Up
11:56am, Wednesday, 05'th Nov 2025
Bio-Techne's Q1 earnings meet expectations, but revenues slip 1%, sending shares lower despite stronger margins.
Here's What Key Metrics Tell Us About Techne (TECH) Q1 Earnings
10:31am, Wednesday, 05'th Nov 2025
While the top- and bottom-line numbers for Techne (TECH) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compar
Techne (TECH) Meets Q1 Earnings Estimates
08:41am, Wednesday, 05'th Nov 2025
Techne (TECH) came out with quarterly earnings of $0.42 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.42 per share a year ago.
Bio-Techne misses quarterly sales estimates on weak biotech demand
07:22am, Wednesday, 05'th Nov 2025
Biotech firm Bio-Techne missed its first-quarter revenue estimates on Wednesday, hurt by sluggish demand for its products amid soft biotech funding environment in China.
BIO-TECHNE DECLARES DIVIDEND
06:30am, Wednesday, 05'th Nov 2025
MINNEAPOLIS , Nov. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended September
Bio-Techne Releases First Quarter Fiscal 2026 Results
06:30am, Wednesday, 05'th Nov 2025
MINNEAPOLIS , Nov. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2025. First Quarter FY2026 Highlights Fi
